I still don’t get it. Unless there was a bidding war for ANDS, which seems unlikely, why would Roche move on ANDS now if the ultimate plan were to acquire ACHN later?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”